Terms: = Gastric cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
37 results:
1. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in gastric cancer.
Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
[TBL] [Abstract] [Full Text] [Related]
2. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
[No Abstract] [Full Text] [Related]
3. LAG3 in gastric cancer: it's complicated.
Ulase D; Behrens HM; Krüger S; Heckl SM; Ebert U; Becker T; Röcken C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10797-10811. PubMed ID: 37311986
[TBL] [Abstract] [Full Text] [Related]
4. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
5. Patient-Reported Outcomes of Individuals with gastric cancer Undergoing Totally Laparoscopic Versus Laparoscopic-Assisted Total Gastrectomy: A Real-World, Propensity Score-Matching Analysis.
Lin GT; Chen JY; Chen QY; Que SJ; Liu ZY; Zhong Q; Wang JB; Lin JX; Lu J; Lin M; Huang ZN; Xie JW; Li P; Huang CM; Zheng CH
Ann Surg Oncol; 2023 Mar; 30(3):1759-1769. PubMed ID: 36414907
[TBL] [Abstract] [Full Text] [Related]
6. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
[TBL] [Abstract] [Full Text] [Related]
7. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?
Borbon LC; Tran CG; Sherman SK; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2022 Oct; 29(11):6936-6946. PubMed ID: 35802214
[TBL] [Abstract] [Full Text] [Related]
8. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Yu Y; Xie Z; Zhao M; Lian X
BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
[TBL] [Abstract] [Full Text] [Related]
9. Positive lymph node ratio is an index in predicting prognosis for remnant gastric cancer with insufficient retrieved lymph node in R0 resection.
Wang H; Qi H; Liu X; Gao Z; Hidasa I; Aikebaier A; Li K
Sci Rep; 2021 Jan; 11(1):2022. PubMed ID: 33479327
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
Gong X; Zhang H
J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors in Krukenberg tumor.
Lionetti R; De Luca M; Travaglino A; Raffone A; Saccone G; Di Cicco A; Insabato L; Mascolo M; D'Armiento M; Zullo F; Corcione F
Arch Gynecol Obstet; 2019 Nov; 300(5):1155-1165. PubMed ID: 31542818
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors].
Zhai XJ; Yu SL; Ma YH; Wang F; Yang MJ; Lian YJ; Yu XX; Fan QX; Song LJ
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2527-2531. PubMed ID: 31484281
[No Abstract] [Full Text] [Related]
13. Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer.
Han G; Shi J; Mi L; Li N; Shi H; Li C; Shan B; Yin F
Future Oncol; 2019 May; 15(14):1617-1627. PubMed ID: 31038363
[No Abstract] [Full Text] [Related]
14. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract] [Full Text] [Related]
15. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
Suzuki M; Yokobori T; Gombodorj N; Yashiro M; Turtoi A; Handa T; Ogata K; Oyama T; Shirabe K; Kuwano H
J Surg Oncol; 2018 Nov; 118(6):966-974. PubMed ID: 30260476
[TBL] [Abstract] [Full Text] [Related]
16. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from akt2.
Qu F; Cao P
Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
[TBL] [Abstract] [Full Text] [Related]
17. [Impact of previous abdominal surgery on the outcomes of laparoscopic resection for colorectal cancer].
Tao J; Wang X; Liu Z; Jiang Z; Guo C; Chen J; Wang Z; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):292-298. PubMed ID: 29577217
[TBL] [Abstract] [Full Text] [Related]
18. Plasma sample based analysis of gastric cancer progression using targeted metabolomics.
Lario S; Ramírez-Lázaro MJ; Sanjuan-Herráez D; Brunet-Vega A; Pericay C; Gombau L; Junquera F; Quintás G; Calvet X
Sci Rep; 2017 Dec; 7(1):17774. PubMed ID: 29259332
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting akt2.
Wang F; Liu J; Zou Y; Jiao Y; Huang Y; Fan L; Li X; Yu H; He C; Wei W; Wang H; Sun G
Oncotarget; 2017 Apr; 8(17):28711-28724. PubMed ID: 28404925
[TBL] [Abstract] [Full Text] [Related]
20. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor prognosis of gastric cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract] [Full Text] [Related]
[Next]
